Le Fort I osteotomy as surgical access
DOI:
https://doi.org/10.35954/SM2020.39.2.10Keywords:
Maxillary Fractures; Odontogenic Cysts; Osteotomy; Osteotomy, Le Fort; Maxillofacial InjuriesAbstract
Multiple surgical approaches have been described for treatment of maxillary lesions. Horizontal osteotomy of the maxilla at the level of the fracture line, as described by Le Fort in 1901, was originally reported as a surgical approach for the resection of nasopharyngeal tumors in 1859. Since the 1970s, this procedure has been popularized in orthognathic surgery for the correction of dentofacial deformities. The Le Fort I type osteotomy was ignored as a surgical approach for several decades, regaining popularity in the late 1980s especially for access to skull base, facial center and nasopharyngeal tumors. The main advantage of this procedure is that it offers a panoramic view of the maxillary sinus and nasal cavity, allows complete exposure and facilitates the complete removal of large lesions without the need for unnecessary extensions and resections of the maxillary bone. We present the case of a maxillary odontogenic keratocyst using the Le Fort I osteotomy as the surgical approach for its treatment.
Recibido para evaluación: Diciembre 2019 Aceptado para publicación: Julio 2020 Correspondencia: Las Heras 1925. C.P.11600. Montevideo, Uruguay. Tel.: (+598) 24873048 interno 171. E-mail de contacto: pablofulgueiras@hotmail.com
Downloads
References
(1) Drommer RB. The history of the “Le Fort I osteotomy”. J Maxillofac Surg 1986; 14(3):119-2. doi: 10.1016/s0301-0503(86)80275-2.
(2) Bell WH, Fonseca RJ, Kenneky JW, Levy BM. Bone healing and revascularization after total maxillary osteotomy. J Oral Surg 1975; 33(4):253-60. PMID: 1054396
(3) Sailer HF, Haers PE, Grätz KW. The Le Fort I osteotomy as a surgical approach for removal of tumours of the midface. J Craniomaxillofac Surg 1999; 27(1):1-6. doi: 10.1016/s1010-5182(99)80002-x.
(4) Speight PM, Takata T. New tumour entities in the 4th edition of the World Health Organization Classification of Head and Neck tumours: odontogenic and maxillofacial bone tumours. Virchows Arch 2018; 472(3):331-339. doi: 10.1007/s00428-017-2182-3.
(5) Alstad V, Abtahi J. Surgical removal of keratocystic odontogenic tumours via a Le Fort I osteotomy approach: a retrospective study of there currence rate. Int J Oral Maxillofac Surg 2017; 46(4):434-439. doi: 10.1016/j.ijom.2017.01.006
(6) Al-Moraissi EA, Dahan AA, Alwadeai MS, Oginni FO, Al-Jamali JM, Alkhutari AS, et al. What surgical treatment has the lowest recurrence rate following the management of keratocystic odontogenic tumor? A larg systematic review and meta-analysis. J Craniomaxillofac Surg 2017; 45(1):131-144. doi: 10.1016/j.jcms.2016.10.013
(7) Chrcanovic BR, Gomez RS. Recurrence probability for keratocystic odontogenic tumors: An analysis of 6427 cases. J Craniomaxillofac Surg 2017; 45(2):244-251. doi: 10.1016/j.jcms.2016.11.010
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Pablo Fulgueiras , Carlos Arismendi. The authors retain their copyright and grant the journal the right of first publication of their work, which will be simultaneously subject to the Creative Commons Attribution 4.0 International License that allows sharing the work as long as the initial publication in this journal is indicated.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Until 2024 we use the Creative Commons Attribution/NonCommercial Attribution 4.0 International License https://creativecommons.org/licenses/by-nc/4.0/deed.es. Which states that: you are free to share, copy and redistribute the material in any medium or format, as well as to adapt, remix, transform and build upon the material. Under the following terms:
Attribution: you must give proper credit , provide a link to the license, and indicate if changes have been made . You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
NonCommercial: you may not use the material for commercial purposes.
As of 2025 authors retain their copyright and assign to the journal the right of first publication of their work, which shall simultaneously be subject to the license https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es that permits sharing, copying and redistribution of the material in any medium or format provided that initial publication in this journal is indicated. Adapt, remix, transform and build upon the material. If you remix, transform, or build from the material, you must distribute your contribution under the same license as the original and may not make use of the material for commercial purposes.
Under the following terms:
1. Attribution: you must give proper credit, provide a link to the license, and indicate whether changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
2. NonCommercial: you may not use the material for commercial purposes.
3. ShareAlike: if you remix, transform or build upon the material, you must distribute your contribution under the same license as the original.
PlumX Metrics
